Aarey Drugs & Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Aarey Drugs & Pharmaceuticals has a total shareholder equity of ₹1.3B and total debt of ₹313.5M, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are ₹3.0B and ₹1.7B respectively. Aarey Drugs & Pharmaceuticals's EBIT is ₹25.4M making its interest coverage ratio 0.6. It has cash and short-term investments of ₹28.9M.
Belangrijke informatie
23.6%
Verhouding schuld/eigen vermogen
₹313.52m
Schuld
| Rente dekkingsratio | 0.6x |
| Contant | ₹28.90m |
| Aandelen | ₹1.33b |
| Totaal verplichtingen | ₹1.71b |
| Totaal activa | ₹3.03b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 524412's short term assets (₹2.8B) exceed its short term liabilities (₹1.7B).
Langlopende schulden: 524412's short term assets (₹2.8B) exceed its long term liabilities (₹39.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 524412's net debt to equity ratio (21.4%) is considered satisfactory.
Schuld verminderen: 524412's debt to equity ratio has increased from 18.7% to 23.6% over the past 5 years.
Schuldendekking: 524412's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: 524412's interest payments on its debt are not well covered by EBIT (0.6x coverage).